[1] Liu XJ,Wang XB,Gao RL,et al. Clinical evaluation of 99mTc-MIBI SPECT in the assessment of coronary artery disease.Nucl Med Commun,1992,13(10):776-779.
[2] Jadvar H,Strauss HW,Segall GM,et al. SPECT and PET in the Evaluation of Coronary Artery Disease1 SCIENTIFIC EXHIBIT.Radiographics,1999,19(4):915-926.
[3] De Sutter J,De Winter F,Van WC,et al. Cardiac fluorine-18 fluorodeoxyglucose imaging using a dual-head gamma camera with coincidence detection:a clinical pilot study.Eur J Nucl Med,2000,27(6):676-685.
[4] Dilsizian V,Acharach SL,Khin MM,et al. Flurie-18-deoxyglucose SPECT and coincidence imaging for myocardial viability:Clinical and technologic issues.J Nucl Cardiol,2001,8(1):75-88.
[5] Berry JJ,B akerjA,Pieper KS,et al. The effect of metabolic mieleu on cardiac PET imaging using flurine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.J Nucl Med,1991,32(8):1518-1525.
[6] Choi Y,Brunken RC,Hawkins RA,et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.Eur J Nucl Med,1993,20(4):308-318.